Edwards Lifesciences (NYSE:EW) Releases Q2 2026 Earnings Guidance
Edwards Lifesciences (NYSE:EW – Get Free Report) updated its second quarter 2026 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 0.700-0.760 for the period, compared to the consensus estimate of 0.750. The company issued revenue guidance of $1.7 billion-$1.7 billion, compared to the consensus revenue estimate of $1.7 billion. Edwards […]
23 Apr 21:52 · The Markets Daily